This could suggest that T cells expressing CTLA-4 and TIGIT accumulate in the circulation of CRC patients during the onset of disease, until they are recruited to the TME as disease progresses, resulting in their accumulation within the tumor tissue. Here, CTLA4 is linked to neoplasm.